Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review
Authors:
Open Access
- 24 May 2021
- journal article
- review article
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 30 (6) , 773-781
Abstract
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is mainly transmitted through respiratory droplets. The symptoms include dry cough, fever, and fatigue; however, high propagation, mutation, and fatality rates have been reported for SARS-CoV-2. This review investigates the structure of SARS-CoV-2, antiviral mechanisms, preventive strategies, and remedies against it. Effective vaccines have been developed by Pfizer (95% effective), AstraZeneca (90% effective), Moderna (94.5% effective) vaccine, among others. However, herd immunity is also required. Probiotics play a major role in the gut health, and some are known to have therapeutic potential against viral infections. Their modes of antiviral activities include direct interaction with targeted viruses, production of antiviral metabolites, and immunomodulatory effects on the host. Hence, probiotics can be a useful prophylactic against COVID-19, and more studies are required on the effects of probiotics against other viral infections that may occur in future.Keywords
This publication has 82 references indexed in Scilit:
- Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate ImmunityPLOS ONE, 2013
- Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virusScientific Reports, 2013
- Antimicrobial Effect of Bacteriocin KU24 Produced by Lactococcus lactis KU24 against Methicillin‐Resistant Staphylococcus aureusJournal of Food Science, 2013
- Inhibitory Influence of Enterococcus faecium on the Propagation of Swine Influenza A Virus In VitroPLOS ONE, 2013
- Multi-Faceted Functions of Secretory IgA at Mucosal SurfacesFrontiers in Immunology, 2013
- Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responsesInternational Immunopharmacology, 2011
- Lactic acid bacteria in the prevention of pneumococcal respiratory infection: Future opportunities and challengesInternational Immunopharmacology, 2011
- Microbiota regulates immune defense against respiratory tract influenza A virus infectionProceedings of the National Academy of Sciences, 2011
- Well‐controlled proinflammatory cytokine responses of Peyer’s patch cells to probiotic Lactobacillus caseiImmunology, 2010
- Interleukin-12 is involved in the enhancement of human natural killer cell activity byLactobacillus caseiShirotaClinical and Experimental Immunology, 2006